Borosil Glass Works is in the business of supplying
Borosilicate Glassware.
The product finds applications in the pharmaceutical
industry (scientific instruments etc.) and consumer segments (e.g. microwave
glass, kitchen table glassware, etc.).
Management expects good growth in both segments as a result of continued
investment by pharmaceutical majors and increased consumer spending.
The company sold its only plant and land in the previous
year and invested 80% of the proceeds in debt funds and 20% in equity
funds. It held about 500cr in liquid
assets last year along with some real estate.
The company reported operating profits of about 3cr on
revenues of 86cr in the last nine months of operations.
Since the plant was sold, the company has been
subcontracting its work. The lack of
tangible capital assets would appear to increase the necessity for the company
to maintain or enhance its brand value from an investor’s perspective.
However, this brand value is under threat with the existence
of spurious goods bearing the company’s brand name.
Moreover, the company faces significant competition from international
and domestic companies entering the market and sourcing supplies from
small/cottage scale fabricators. It is also
adversely impacted by unrestricted imports and dumping of scientific and
industrial products.
Furthermore, plastics can be substituted for glassware and
poses a threat to the company’s revenues.
Since it is a net importer, it is exposed to a weakening
INR.
Management have stated their intention to grow inorganically
and the substantial pot of liquid assets is at risk of being dissipated. The investor would be exposed to the capital
allocation expertise of management. This
is true with most equity investments but more so when management intentions to deploy
liquid funds are clear, and their expertise is untested.
Comments
Post a Comment